MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Nanostructures Get in Shape for Drug Delivery

By 2014, $2.6 trillion in global manufactured goods, or about 15% of total global output, will incorporate nanotechnology, according to the independent advisory firm Lux Research (New York City; www.luxresearchinc.com). One of the areas where the continued growth will be most apparent is in the healthcare sector. Nanotechnology research with implications for the medical device industry is progressing rapidly, and academic institutions and medical device firms continue to make strides in bridging the gap between research and commercialization. The University of California at Los Angeles has announced the launch of the California NanoSystems Institute (Los Angeles; www.cnsi.ucla.edu), created with the expressed purpose of fostering partnerships between industry and university researchers. Elsewhere in the world, a recently formed company in the United Kingdom, NanoCentral (www.nanocentral.eu), offers to advise and assist companies in implementing nanotechnology equipment and services within existing business models. In this feature, MPMN reports on several advancements in nanotechnology that have the potential to revolutionize medical product manufacturing in the years ahead. The innovations covered could have applications as varied as drug delivery, power supply, implantable device components, diagnosis, and detection.

SPECIAL FEATURE: EMERGING TECHNOLOGIES

Nanostructures Get in Shape for Drug Delivery
Researchers have discovered how to make synthetic polymer molecules form into long cylinders, a nanostructure potentially suited for drug-delivery applications.

Block copolymers can be found in rubber soles for shoes, and, more recently, in portable memory sticks (flash drives) for computers. Soon, the material might be found in the human body as well. Researchers have discovered how to make synthetic polymer molecules assemble and form into long cylinders, a nanostructure potentially suited for drug-delivery applications. The finding was first reported in the August issue of Science by a research team lead by Darrin Pochan, associate professor at the University of Delaware (Newark, DE), and Karen Wooley, professor at Washington University (St. Louis).

“A block copolymer is a long-chain molecule, a length of which, or block, is chemically different than the other,” says Pochan. “So, you put them in a solution where one of the blocks repels and tries to get away and the other doesn’t, which is how you get different shapes to form.”

The scientists used a tri-block copolymer composed of polyacrylic acid, polymethylacrylate, and polystyrene. They introduced it to a solution of tetrahydrofuran and water, as well as organic diamines. The technique relied on divalent organic counter ions and solvent mixtures to drive the organization of the block copolymers down specific pathways into long, one-dimensional structures.

In the past, self-assembly on the nanoscale has typically produced simple shapes, such as spheres, which present problems for drug delivery. “If you put little balls full of a drug into the bloodstream, the body’s organs and immune system will clear it out in a day,” Pochan says. “But, if you place the molecules into long, floppy cylinders, they may stay in the body for weeks.”

Floppy cylinder nanostructures can also be formed to provide multiple compartments (unlike a sphere, which is capable of providing only one compartment)—another potential advantage for drug delivery. Multicompartmental structures suggest intriguing possibilities, says Pochan, including devices that could store different drugs in separate compartments, thereby enabling a single device to deliver an entire drug regimen.

In addition to new shapes, the research has also yielded a bottom-up approach for building nanostructures. “Bottom-up manufacturing has gotten a bad rap in recent years, but this research has made it relevant for nanomanufacturing,” Pochan says. “Rather than design a large structure or component and use lithography to form it into what you want, our goal is to design a molecule with all the information it needs built-in, and then you throw it in water and it zips up into the desired complex shape and size.”

“It’s all about constructing materials and nanostructures in an easy way,” he adds.

University of Delaware, Newark, DE
www.udel.edu

Washington University, St. Louis, MO
www.wustl.edu

Copyright ©2008 Medical Product Manufacturing News
Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish